On 7/5/24, Insmed Inc (NASDAQ: INSM) stock enjoyed a major increase of 12.9%, closing at $70.00. This advance was accompanied by normal trading volume. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 1.5% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be in line with the cost of capital, INSM is expected to continue to be Value Creation neutral.
Insmed is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment